These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3100309)

  • 1. Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study.
    Kahaly G; Schrezenmeir J; Krause U; Schweikert B; Meuer S; Muller W; Dennebaum R; Beyer J
    Eur J Clin Invest; 1986 Oct; 16(5):415-22. PubMed ID: 3100309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Berghout A; Krenning EP; van der Gaag R; Koornneef L; Wiersinga WM
    N Engl J Med; 1989 Nov; 321(20):1353-9. PubMed ID: 2519530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Blank L; Berghout A; Koornneef L; Wiersinga WM
    Lancet; 1993 Oct; 342(8877):949-54. PubMed ID: 8105213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.
    Bartalena L; Marcocci C; Bogazzi F; Panicucci M; Lepri A; Pinchera A
    N Engl J Med; 1989 Nov; 321(20):1349-52. PubMed ID: 2811943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
    J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Graves' ophthalmopathy with cyclosporin A.
    Witte A; Landgraf R; Markl A; Boergen KP; Hasenfratz G; Pickardt CR
    Klin Wochenschr; 1985 Oct; 63(19):1000-4. PubMed ID: 3840854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic role of adhesion molecules sELAM-1 and sICAM-1 in glucocorticoid therapy of active ophthalmopathy].
    Modelska-Ziółkiewicz A; Gembicki M; Bednarek J; Sowiński J
    Pol Arch Med Wewn; 2003 May; 109(5):469-75. PubMed ID: 14768175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe Graves' ophthalmopathy with cyclosporin A.
    Utech C; Wulle KG; Bieler EU; Pfannenstiel P; Panitz N; Kiefer H
    Acta Endocrinol (Copenh); 1985 Dec; 110(4):493-8. PubMed ID: 3911714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy].
    Yang H; Wu Z; Huang X; Xie C; Yang P
    Yan Ke Xue Bao; 1999 Jun; 15(2):78-80. PubMed ID: 12579704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive therapies in patients with Graves' ophthalmopathy].
    Wang J; Wang YT; Shao JQ; Wang X; Du H
    Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):125-7. PubMed ID: 15059413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy.
    Kung AW; Michon J; Tai KS; Chan FL
    Thyroid; 1996 Oct; 6(5):381-4. PubMed ID: 8936659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciclosporine and Graves' ophthalmopathy.
    Gayno JP; Strauch G
    Horm Res; 1987; 26(1-4):190-7. PubMed ID: 3596468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
    Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy.
    Wiersinga WM; Smit T; Schuster-Uittenhoeve AL; van der Gaag R; Koornneef L
    Ophthalmologica; 1988; 197(2):75-84. PubMed ID: 3186212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Hiromatsu Y; Tanaka K; Sato M; Kuroki T; Nonaka K; Kojima K; Nishimura H; Nishida H; Kaise N
    Endocr J; 1993 Feb; 40(1):63-72. PubMed ID: 7951498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy.
    De Bellis A; Bizzarro A; Conte M; Coronella C; Solimeno S; Perrino S; Sansone D; Guaglione M; Wall JR; Bellastella A
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):388-95. PubMed ID: 12919164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin improves Graves' ophthalmopathy.
    Weetman AP; McGregor AM; Ludgate M; Beck L; Mills PV; Lazarus JH; Hall R
    Lancet; 1983 Aug; 2(8348):486-9. PubMed ID: 6136647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Graves' ophthalmopathy with cyclosporin A.
    Kvetny J; Frandsen NE; Johnsen T; Dieperinck H; Mogensen E
    Acta Med Scand; 1986; 220(2):189-91. PubMed ID: 3535393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.